OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+15.95%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$41.9M
AUM Growth
+$41.9M
(-9.2%)
Cap. Flow
-$8.75M
Cap. Flow
% of AUM
-20.88%
Top 10 Holdings %
Top 10 Hldgs %
48.42%
Holding
52
New
2
Increased
17
Reduced
26
Closed
5
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$3.23M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.04M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$1.14M |
| 4 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$591K |
| 5 |
Fortress Biotech
FBIO
|
$374K |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$5.52M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$5.37M |
| 3 |
iShares Biotechnology ETF
IBB
|
$2.06M |
| 4 |
Biogen
BIIB
|
$884K |
| 5 |
Amgen
AMGN
|
$848K |
Sector Composition
| 1 | Healthcare | 97.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $3.68M | 8.78% | 94,300 +82,800 | +720% | +$3.23M |
|
2
ProQR Therapeutics
PRQR
$237M
| $2.68M | 6.4% | 138,461 -15,385 | -10% | -$298K |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.42M | 5.78% | 82,430 +69,430 | +534% | +$2.04M |
|
4
Mettler-Toledo International
MTD
$26.8B
| $1.97M | 4.7% | 3,235 -359 | -10% | -$219K |
|
5
Illumina
ILMN
$15.8B
| $1.83M | 4.36% | 4,972 -380 | -7% | -$139K |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.79M | 4.26% | 12,847 -887 | -6% | -$123K |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $1.68M | 4.02% | 8,727 -604 | -6% | -$116K |
|
8
MEI Pharma
MEIP
$160M
| $1.55M | 3.71% | 360,000 -40,000 | -10% | -$172K |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.49M | 3.55% | 19,288 -1,546 | -7% | -$119K |
|
10
Ionis Pharmaceuticals
IONS
$6.79B
| $1.2M | 2.87% | 23,293 -623 | -3% | -$32.1K |
|
11
Qiagen
QGEN
$10.1B
| $1.2M | 2.86% | 31,620 -1,100 | -3% | -$41.7K |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.18M | 2.82% | 13,499 -613 | -4% | -$53.6K |
|
13
Agios Pharmaceuticals
AGIO
$2.19B
| $1.17M | 2.78% | 15,102 -731 | -5% | -$56.4K |
|
|
ACHN
14
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.14M | 2.71% | +308,569 | New | +$1.14M |
|
15
Alkermes
ALKS
$4.78B
| $1.07M | 2.56% | 25,242 -310 | -1% | -$13.2K |
|
|
LOXO
16
DELISTED
Loxo Oncology, Inc
LOXO
| $1.06M | 2.53% | 6,210 -690 | -10% | -$118K |
|
17
FibroGen
FGEN
$47.8M
| $1.04M | 2.49% | 17,138 -1,285 | -7% | -$78.1K |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.02M | 2.44% | 2,531 -167 | -6% | -$67.5K |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $956K | 2.28% | 9,854 -482 | -5% | -$46.8K |
|
|
ADMS
20
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $891K | 2.13% | 44,500 +29,500 | +197% | +$591K |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $872K | 2.08% | 9,747 +23 | +0.2% | +$2.06K |
|
22
Incyte
INCY
$16.5B
| $853K | 2.04% | 12,345 +24 | +0.2% | +$1.66K |
|
23
Nektar Therapeutics
NKTR
$568M
| $720K | 1.72% | 11,803 +3,271 | +38% | +$200K |
|
24
Pacira BioSciences
PCRX
$1.2B
| $553K | 1.32% | 11,250 -1,250 | -10% | -$61.4K |
|
|
ICPT
25
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $505K | 1.21% | 3,998 | – | – |
|